{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/coeliac-disease/background-information/complications/","result":{"pageContext":{"chapter":{"id":"09a61360-9601-5caa-84af-2136bd4a7603","slug":"complications","fullItemName":"Complications","depth":2,"htmlHeader":"<!-- begin field fa5b8d21-eb2c-44f3-ba8b-1cef4cfa2b5d --><h2>What are the complications?</h2><!-- end field fa5b8d21-eb2c-44f3-ba8b-1cef4cfa2b5d -->","summary":"","htmlStringContent":"<!-- begin item 841cf7d6-bce8-47c8-99f3-41c3761bd7f3 --><!-- begin field 86341110-6d2f-422f-b9fc-54bf020c5a34 --><p><strong>Possible complications of undiagnosed, untreated, or undertreated coeliac disease include:</strong></p><ul><li>Reduced quality of life.<ul><li>This may be due to social implications of adhering to a gluten-free diet, including social isolation, avoiding eating out because of the risk of contamination, embarrassment with friends and colleagues, fear of inadvertent exposure to gluten, and the increased costs associated with a gluten-free diet [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Ludvigsson, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Mooney, 2014a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Lebwohl, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Caio, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Clappison, 2020</a>].</li></ul></li><li>Depression, anxiety, and possible eating disorders, especially in young people [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">NICE, 2015b</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Ludvigsson, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">McAllister, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Clappison, 2020</a>].<ul><li>See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/depression/\">Depression</a>, <a class=\"topic-reference external-reference\" href=\"/topics/depression-in-children/\">Depression in children</a>, <a class=\"topic-reference external-reference\" href=\"/topics/generalized-anxiety-disorder/\">Generalized anxiety disorder</a>, and <a class=\"topic-reference external-reference\" href=\"/topics/eating-disorders/\">Eating disorders</a> for more information.</li></ul></li><li>Faltering growth and delayed puberty in children [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Murch, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Ludvigsson, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Thomas, 2018</a>].<ul><li>See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/faltering-growth/\">Faltering growth</a> for more information.</li></ul></li><li>Nutritional deficiencies due to malabsorption and gastrointestinal inflammation [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Thomas, 2018</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Al-Toma, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Caio, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Husby, 2019</a>].</li><li>Anaemia due to malabsorption and deficiency of iron, folate, and/or vitamin B12 [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Al-Toma, 2019</a>].<ul><li>Iron deficiency is present in 7–80% of people with coeliac disease at diagnosis. Coeliac disease is present in 2–5% of people with iron deficiency anaemia. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/anaemia-iron-deficiency/\">Anaemia - iron deficiency</a> for more information.</li><li>Vitamin B12 deficiency is present in 5–41% of untreated cases of coeliac disease. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/anaemia-b12-folate-deficiency/\">Anaemia - B12 and folate deficiency</a> for more information.</li></ul></li><li>Reduced bone mineral density including osteoporosis and osteopenia [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Mooney, 2014a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Thomas, 2018</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Al-Toma, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Husby, 2019</a>].<ul><li>This is due to malabsorption of calcium and/or vitamin D, and increases the risk of fragility fractures. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/osteoporosis-prevention-of-fragility-fractures/\">Osteoporosis - prevention of fragility fractures</a>, <a class=\"topic-reference external-reference\" href=\"/topics/vitamin-d-deficiency-in-adults-treatment-prevention/\">Vitamin D deficiency in adults - treatment and prevention</a>, and <a class=\"topic-reference external-reference\" href=\"/topics/vitamin-d-deficiency-in-children/\">Vitamin D deficiency in children</a>.</li></ul></li><li>Hyposplenism or asplenism [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Ludvigsson, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Mooney, 2014a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Simons, 2018</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Caio, 2019</a>].<ul><li>Hyposplenism is closely associated with the development of complications and other autoimmune diseases associated with coeliac disease, and is a risk factor for encapsulated bacterial infections (such as Pneumococcus, <em>Haemophilus influenzae</em>, and meningococcus infections) and sepsis. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/sepsis/\">Sepsis</a> for more information.</li></ul></li><li>Malignancy, such as Hodgkin's and non-Hodgkin's lymphoma (including enteropathy-associated T-cell lymphoma [EATL] and less frequently B-cell non-Hodgkin's lymphoma), small bowel adenocarcinoma, and pancreatic cancer [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Ludvigsson, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Lebwohl, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Thomas, 2018</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Caio, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Al-Toma, 2019</a>].<ul><li>People with coeliac disease are at increased risk of cancer, including a two-fold to four-fold increased risk of non-Hodgkin’s lymphoma, and a more than 30-fold increased risk of small bowel adenocarcinoma, and they have a 1.4-fold increased risk of death [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Lebwohl, 2015</a>].</li></ul></li><li>Refractory coeliac disease.<ul><li>This is a rare condition, defined as persistent or recurrent symptoms and villous atrophy despite strict adherence to a gluten-free diet for at least 12 months, affecting about 1–1.5% of coeliac disease cases. Persistent symptoms typically include malabsorption, weight loss, and nutritional deficiencies. It is classified into two subtypes that have a differing prognosis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Mooney, 2014a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Al-Toma, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Caio, 2019</a>].</li><li>A single-centre cohort study of people with refractory coeliac disease (n = 57) found the overall cumulative 5-year survival is 80% and 45% in people with type I and type II disease, respectively [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Rubio-Tapia, 2009</a>]. The rare lymphoma, EATL, is strongly associated with type II disease, and is linked to its poorer prognosis.</li><li>Ulcerative jejunoileitis is a rare complication of refractory coeliac disease characterized by inflammatory ulceration of the small bowel [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Ludvigsson, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Caio, 2019</a>].</li></ul></li></ul><!-- end field 86341110-6d2f-422f-b9fc-54bf020c5a34 --><!-- end item 841cf7d6-bce8-47c8-99f3-41c3761bd7f3 -->","topic":{"id":"1c1a5a3f-9b4d-5aca-b1c7-548672455692","topicId":"b0551c5c-9ab6-4db2-b8e5-27b98c6108ac","topicName":"Coeliac disease","slug":"coeliac-disease","lastRevised":"Last revised in May 2020","chapters":[{"id":"1ab49395-0a38-5106-ac8c-081d06df8957","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"42fe31c7-8b64-527e-bd5e-51c32714ee29","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"26b08904-13dc-5b32-8bc4-2549fa573fb3","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"5c0dee49-ba90-52f3-a99a-676cb4ca5418","slug":"changes","fullItemName":"Changes"},{"id":"875d3bb9-e2eb-51af-b90b-a59a08a4c149","slug":"update","fullItemName":"Update"}]},{"id":"9ced2297-bd68-58b0-b12e-d660074f8e9e","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"394005c9-726f-5f88-be40-717a7d0adb86","slug":"goals","fullItemName":"Goals"},{"id":"2f234477-2111-51de-8800-18b0231b7b5c","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"82c4f886-1b62-5a2f-b956-e939a3736a77","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"352349eb-c34b-5c8a-8f35-cc52c1e427e0","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"ba3abfa3-9c4f-527d-bc4a-30d501245cb7","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"67796a49-6946-5a26-9be6-3d4e8ae58914","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"f7799373-9e95-51e7-beb7-1fecaaa38b46","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"d877907c-0181-5747-953a-1057a01509ee","slug":"definition","fullItemName":"Definition"},{"id":"13d4bc73-968e-5163-b7b1-3a66b2f0e52c","slug":"prevalence","fullItemName":"Prevalence"},{"id":"f33b46df-e16f-5d24-a608-1b5b4a4b605a","slug":"causes","fullItemName":"Causes"},{"id":"09a61360-9601-5caa-84af-2136bd4a7603","slug":"complications","fullItemName":"Complications"},{"id":"9db3868a-f808-5034-8563-58a2c84ab545","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"13e9616c-5ad7-54a8-af68-dad57366685f","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"77ada14b-2c51-5bf2-894b-526f099ef23e","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"d056d742-1aa4-57bc-8e9b-3730a715a6dd","slug":"assessment","fullItemName":"Assessment"},{"id":"98e1c8e5-e970-57a5-a01e-0d4ad52bc8ca","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"4561ec77-0c01-5346-8f45-78e225038140","fullItemName":"Management","slug":"management","subChapters":[{"id":"ee522102-0563-555f-a5b5-a9199c67b6a8","slug":"management-of-confirmed-coeliac-disease","fullItemName":"Scenario: Management of confirmed coeliac disease"}]},{"id":"e9edb239-af7b-54d7-ad64-dadf49939e27","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"bc5fb8ef-a4c4-581b-8828-fa524bfc69ca","slug":"gluten-free-products","fullItemName":"Gluten-free products"}]},{"id":"76c25337-4d0a-5036-b7cf-1c7ca39a7e48","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"6001d4b8-f58d-5d70-a396-3f47044d6a24","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"cf74b6f9-a29b-5108-b99b-0d2d5782850a","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"472110e6-ab58-582f-8614-7d056d174365","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"4c098beb-df9b-5e8d-8fdf-0197b1dd54d3","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"9a97c354-b836-5bab-8cbf-eb9d5698f9cb","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"a79c40d9-503b-5914-bb11-f0370fa4119a","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"aa655679-10e1-5946-87a1-3dfdf6ad91f3","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"f7799373-9e95-51e7-beb7-1fecaaa38b46","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}